Risk stratification of Asian patients with heart failure and reduced ejection fraction: the effectiveness of the Echo Heart Failure Score

Lena Bosch; Erberto Carluccio; Stefano Coiro; Lingli Gong; David Sim; Poh Shuan Daniel Yeo; Fazlur Jaufeerally; Kui T.G. Leong; Hean Yee Ong; Ng T. Pin; Arthur Mark Richards; Fatih Arslan; Lieng H Ling; Carolyn S P Lam; Giuseppe Ambrosio

doi:10.1002/ejhf.922

Risk stratification of Asian patients with heart failure and reduced ejection fraction: the effectiveness of the Echo Heart Failure Score

Lena Bosch
, Erberto Carluccio
, Stefano Coiro
, Lingli Gong
, David Sim
, Poh Shuan Daniel Yeo
, Fazlur Jaufeerally
, Kui T.G. Leong
, Hean Yee Ong
, Ng T. Pin
, Arthur Mark Richards
, Fatih Arslan
, Lieng H Ling
, Carolyn S P Lam
, Giuseppe Ambrosio

Research output: Contribution to journal › Article › Academic › peer-review

3 Downloads (Pure)

Original language	English
Pages (from-to)	1732-1735
Number of pages	4
Journal	European Journal of Heart Failure
Volume	19
Issue number	12
DOIs	https://doi.org/10.1002/ejhf.922
Publication status	Published - 1 Dec 2017

Keywords

Echocardiography
Ethnicity
Heart Failure
Reduced ejection fraction
Risk stratification

Access to Document

10.1002/ejhf.922

Bosch_et_al-2017-European_Journal_of_Heart_FailureFinal published version, 268 KBLicence: Taverne

Cite this

Bosch, L., Carluccio, E., Coiro, S., Gong, L., Sim, D., Yeo, P. S. D., Jaufeerally, F., Leong, K. T. G., Ong, H. Y., Pin, N. T., Richards, A. M., Arslan, F., Ling, L. H., Lam, C. S. P., & Ambrosio, G. (2017). Risk stratification of Asian patients with heart failure and reduced ejection fraction: the effectiveness of the Echo Heart Failure Score. European Journal of Heart Failure, 19(12), 1732-1735. https://doi.org/10.1002/ejhf.922

@article{12727e7ad97541faa26bb769e8549474,

title = "Risk stratification of Asian patients with heart failure and reduced ejection fraction: the effectiveness of the Echo Heart Failure Score",

keywords = "Echocardiography, Ethnicity, Heart Failure, Reduced ejection fraction, Risk stratification",

author = "Lena Bosch and Erberto Carluccio and Stefano Coiro and Lingli Gong and David Sim and Yeo, \{Poh Shuan Daniel\} and Fazlur Jaufeerally and Leong, \{Kui T.G.\} and Ong, \{Hean Yee\} and Pin, \{Ng T.\} and Richards, \{Arthur Mark\} and Fatih Arslan and Ling, \{Lieng H\} and Lam, \{Carolyn S P\} and Giuseppe Ambrosio",

note = "Funding Information: This work was supported by a Centre Grant from the National Medical Research Council of Singapore (grant number R-172-003-2190511) and by the Alexandre Suerman MD/PhD programme from the UMC Utrecht. Conflict of interest: C.S.P.L. is supported by a Clinician Scientist Award from the National Medical Research Council of Singapore; has received research support from Boston Scientific, Bayer, Thermofisher, Medtronic, and Vifor Pharma; and has consulted for Bayer, Novartis, Takeda, Merck, Astra Zeneca, Janssen Research \& Development, LLC, Menarini, Boehringer Ingelheim, and Abbott Diagnostics. A.M.R. is supported by a Senior Translational Research Award from the National Medical Research Council of Singapore and is Principal Investigator for the Centre Grant made to the National University Heart Centre, Singapore, which funded this study. He has consulted for, and received research support from, Bayer, Novartis, Merck, Medtronic, Pfizer, Boehringer Ingelheim, Astra Zeneca, Roche Diagnostics, Thermo Fisher, Alere, Critical Diagnostics, and Abbott Diagnostics. Funding Information: This work was supported by a Centre Grant from the National Medical Research Council of Singapore (grant number R-172-003-2190511) and by the Alexandre Suerman MD/PhD programme from the UMC Utrecht. Conflict of interest: C.S.P.L. is supported by a Clinician Scientist Award from the National Medical Research Council of Singapore; has received research support from Boston Scientific, Bayer, Thermofisher, Medtronic, and Vifor Pharma; and has consulted for Bayer, Novartis, Takeda, Merck, Astra Zeneca, Janssen Research \& Development, LLC, Menarini, Boehringer Ingelheim, and Abbott Diagnostics. A.M.R. is supported by a Senior Translational Research Award from the National Medical Research Council of Singapore and is Principal Investigator for the Centre Grant made to the National University Heart Centre, Singapore, which funded this study. He has consulted for, and received research support from, Bayer, Novartis, Merck, Medtronic, Pfizer, Boehringer Ingelheim, Astra Zeneca, Roche Diagnostics, Thermo Fisher, Alere, Critical Diagnostics, and Abbott Diagnostics. The authors would like to thank the clinicians, clinical research coordinators, and sonographers in their institutions who assisted with the conduct of this study. This work was supported by a Centre Grant from the National Medical Research Council of Singapore (grant number R-172-003-2190511) and by the Alexandre Suerman MD/PhD programme from the UMC Utrecht. Conflict of interest: C.S.P.L. is supported by a Clinician Scientist Award from the National Medical Research Council of Singapore; has received research support from Boston Scientific, Bayer, Thermofisher, Medtronic, and Vifor Pharma; and has consulted for Bayer, Novartis, Takeda, Merck, Astra Zeneca, Janssen Research \& Development, LLC, Menarini, Boehringer Ingelheim, and Abbott Diagnostics. A.M.R. is supported by a Senior Translational Research Award from the National Medical Research Council of Singapore and is Principal Investigator for the Centre Grant made to the National University Heart Centre, Singapore, which funded this study. He has consulted for, and received research support from, Bayer, Novartis, Merck, Medtronic, Pfizer, Boehringer Ingelheim, Astra Zeneca, Roche Diagnostics, Thermo Fisher, Alere, Critical Diagnostics, and Abbott Diagnostics.",

year = "2017",

month = dec,

day = "1",

doi = "10.1002/ejhf.922",

language = "English",

volume = "19",

pages = "1732--1735",

journal = "European Journal of Heart Failure",

issn = "1388-9842",

publisher = "John Wiley \& Sons Inc.",

number = "12",

}

Bosch, L, Carluccio, E, Coiro, S, Gong, L, Sim, D, Yeo, PSD, Jaufeerally, F, Leong, KTG, Ong, HY, Pin, NT, Richards, AM, Arslan, F, Ling, LH, Lam, CSP & Ambrosio, G 2017, 'Risk stratification of Asian patients with heart failure and reduced ejection fraction: the effectiveness of the Echo Heart Failure Score', European Journal of Heart Failure, vol. 19, no. 12, pp. 1732-1735. https://doi.org/10.1002/ejhf.922

TY - JOUR

T1 - Risk stratification of Asian patients with heart failure and reduced ejection fraction

T2 - the effectiveness of the Echo Heart Failure Score

AU - Bosch, Lena

AU - Carluccio, Erberto

AU - Coiro, Stefano

AU - Gong, Lingli

AU - Sim, David

AU - Yeo, Poh Shuan Daniel

AU - Jaufeerally, Fazlur

AU - Leong, Kui T.G.

AU - Ong, Hean Yee

AU - Pin, Ng T.

AU - Richards, Arthur Mark

AU - Arslan, Fatih

AU - Ling, Lieng H

AU - Lam, Carolyn S P

AU - Ambrosio, Giuseppe

N1 - Funding Information: This work was supported by a Centre Grant from the National Medical Research Council of Singapore (grant number R-172-003-2190511) and by the Alexandre Suerman MD/PhD programme from the UMC Utrecht. Conflict of interest: C.S.P.L. is supported by a Clinician Scientist Award from the National Medical Research Council of Singapore; has received research support from Boston Scientific, Bayer, Thermofisher, Medtronic, and Vifor Pharma; and has consulted for Bayer, Novartis, Takeda, Merck, Astra Zeneca, Janssen Research & Development, LLC, Menarini, Boehringer Ingelheim, and Abbott Diagnostics. A.M.R. is supported by a Senior Translational Research Award from the National Medical Research Council of Singapore and is Principal Investigator for the Centre Grant made to the National University Heart Centre, Singapore, which funded this study. He has consulted for, and received research support from, Bayer, Novartis, Merck, Medtronic, Pfizer, Boehringer Ingelheim, Astra Zeneca, Roche Diagnostics, Thermo Fisher, Alere, Critical Diagnostics, and Abbott Diagnostics. Funding Information: This work was supported by a Centre Grant from the National Medical Research Council of Singapore (grant number R-172-003-2190511) and by the Alexandre Suerman MD/PhD programme from the UMC Utrecht. Conflict of interest: C.S.P.L. is supported by a Clinician Scientist Award from the National Medical Research Council of Singapore; has received research support from Boston Scientific, Bayer, Thermofisher, Medtronic, and Vifor Pharma; and has consulted for Bayer, Novartis, Takeda, Merck, Astra Zeneca, Janssen Research & Development, LLC, Menarini, Boehringer Ingelheim, and Abbott Diagnostics. A.M.R. is supported by a Senior Translational Research Award from the National Medical Research Council of Singapore and is Principal Investigator for the Centre Grant made to the National University Heart Centre, Singapore, which funded this study. He has consulted for, and received research support from, Bayer, Novartis, Merck, Medtronic, Pfizer, Boehringer Ingelheim, Astra Zeneca, Roche Diagnostics, Thermo Fisher, Alere, Critical Diagnostics, and Abbott Diagnostics. The authors would like to thank the clinicians, clinical research coordinators, and sonographers in their institutions who assisted with the conduct of this study. This work was supported by a Centre Grant from the National Medical Research Council of Singapore (grant number R-172-003-2190511) and by the Alexandre Suerman MD/PhD programme from the UMC Utrecht. Conflict of interest: C.S.P.L. is supported by a Clinician Scientist Award from the National Medical Research Council of Singapore; has received research support from Boston Scientific, Bayer, Thermofisher, Medtronic, and Vifor Pharma; and has consulted for Bayer, Novartis, Takeda, Merck, Astra Zeneca, Janssen Research & Development, LLC, Menarini, Boehringer Ingelheim, and Abbott Diagnostics. A.M.R. is supported by a Senior Translational Research Award from the National Medical Research Council of Singapore and is Principal Investigator for the Centre Grant made to the National University Heart Centre, Singapore, which funded this study. He has consulted for, and received research support from, Bayer, Novartis, Merck, Medtronic, Pfizer, Boehringer Ingelheim, Astra Zeneca, Roche Diagnostics, Thermo Fisher, Alere, Critical Diagnostics, and Abbott Diagnostics.

PY - 2017/12/1

Y1 - 2017/12/1

KW - Echocardiography

KW - Ethnicity

KW - Heart Failure

KW - Reduced ejection fraction

KW - Risk stratification

UR - https://www.scopus.com/pages/publications/85028919917

U2 - 10.1002/ejhf.922

DO - 10.1002/ejhf.922

M3 - Article

AN - SCOPUS:85028919917

SN - 1388-9842

VL - 19

SP - 1732

EP - 1735

JO - European Journal of Heart Failure

JF - European Journal of Heart Failure

IS - 12

ER -

Risk stratification of Asian patients with heart failure and reduced ejection fraction: the effectiveness of the Echo Heart Failure Score

Keywords

Access to Document

Other files and links

Cite this